Multicenter, randomized, placebo-controlled, double-blind clinical trial of escitalopram on the progression-delaying effects in Alzheimer's disease.
about
Multicenter, randomized, placebo-controlled, double-blind clinical trial of escitalopram on the progression-delaying effects in Alzheimer's disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Multicenter, randomized, place ...... ffects in Alzheimer's disease.
@en
Multicenter, randomized, place ...... ffects in Alzheimer's disease.
@nl
type
label
Multicenter, randomized, place ...... ffects in Alzheimer's disease.
@en
Multicenter, randomized, place ...... ffects in Alzheimer's disease.
@nl
prefLabel
Multicenter, randomized, place ...... ffects in Alzheimer's disease.
@en
Multicenter, randomized, place ...... ffects in Alzheimer's disease.
@nl
P2093
P2860
P356
P1476
Multicenter, randomized, place ...... effects in Alzheimer's disease
@en
P2093
Bo Kyung Sohn
Dong Young Lee
Eun Hyun Seo
Jae-Hwa Bak
Jin Hyeong Jhoo
Jong Inn Woo
Jong-Min Lee
Ki Woong Kim
Min Soo Byun
Myeong-Il Han
P2860
P304
P356
10.1002/GPS.4384
P407
P50
P577
2015-11-09T00:00:00Z